Primary central nervous system lymphoma (PCNSL) is a rare disease that is managed differently from other primary brain tumors and other types of systemic lymphomas. The use of high-dose ...
The Union for International Cancer Control (UICC) has launched its new campaign for World Cancer Day 2025-2027, "United for ...
A group led by the Department of Neurosurgery, Brain Research Institute, Niigata University, has succeeded in the diagnosis ...
News Medical on MSN9d
Early detection of tumor spread improves treatment outcomesA group led by the Department of Neurosurgery, Brain Research Institute, Niigata University succeeded in the diagnosis of ...
A group at Niigata University succeeded in the early diagnosis of leptomeningeal disease in H3K27M-mutant diffuse midline ...
Surgical resection significantly improved overall survival and cancer-specific survival in primary central nervous system lymphoma (PCNSL).
A group led by the Department of Neurosurgery, Brain Research Institute, Niigata University succeeded in the diagnosis of ...
Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...
Patients with lymphoma or leukemia with methotrexate-induced acute kidney injury experienced improved renal outcomes ...
Glucarpidase significantly improved kidney function for patients who developed acute kidney injury from high-dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback